Wego Intervention Receives Ukrainian Medical Device Registration Certificate for Its Proprietary Metallic Drug-Eluting Stent System
Kinhely
Cardiovascular Interventional Device R&D and Production Company
Recently, the metal drug-eluting stent system independently developed by Shenzhen Kinhely Bio-Tech Co., Ltd., a subsidiary of Weigao Interventional Group, passed the review by Ukrainian regulatory authorities and obtained the Ukrainian medical device registration certificate, marking its official access to the Eastern European market.
Weigao Interventional has always adhered to the core philosophy of innovation-driven development and strictly complies with international quality standards. This certification not only concretely demonstrates the company’s comprehensive capabilities in research and development, production, and compliance management, but also reaffirms its steadfast commitment to serving patients worldwide.
Looking ahead, Weigao Interventional will continue to deepen its presence in the international market, increase R&D investment, and enhance product quality, serving global patients with superior and safer products, thereby laying a solid foundation for Chinese-made medical devices to expand overseas and establish a firm foothold in the global market.
